Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing
暂无分享,去创建一个
Peiyong Jiang | Yama W. L. Zheng | Tak Y. Leung | Hao Sun | Kypros H. Nicolaides | Jun Wang | Xiuqing Zhang | K. Nicolaides | P. Jiang | K. C. Chan | T. Leung | Y. Lo | E. Lau | Hao Sun | Fiona M. F. Lun | Eric Z. Chen | R. Chiu | T. Lau | C. Oudejans | R. Akolekar | J. V. van Vugt | A. Go | W. Leung | M. Tang | K. C. Allen Chan | Y. M. Dennis Lo | Ranjit Akolekar | Yongjie Jin | Tze K. Lau | Lisa Y. S. Chan | Yongjie Jin | Rossa W. K. Chiu | Attie T. J. I. Go | Elizabeth T. Lau | William W. K. To | Wing C. Leung | Rebecca Y. K. Tang | Sidney K. C. Au-Yeung | Helena Lam | Yu Y. Kung | Xiuqing Zhang | John M. G. van Vugt | Ryoko Minekawa | Mary H. Y. Tang | Cees B. M. Oudejans | R. Tang | W. K. To | R. Minekawa | H. Lam | L. Chan | Y. Y. Kung | Jun Wang | L. Chan | Y. Lo | Lisa Y. S. Chan
[1] C. Cantor,et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.
[2] A. Rudnicka,et al. First-trimester or second-trimester screening, or both, for Down's syndrome. , 2005, New England Journal of Medicine.
[3] Susan Gross,et al. Clinical practice. Prenatal screening for aneuploidy. , 2009, The New England journal of medicine.
[4] Siu-Ming Yiu,et al. SOAP2: an improved ultrafast tool for short read alignment , 2009, Bioinform..
[5] Ann Tabor,et al. RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMEN , 1986, The Lancet.
[6] Yama W. L. Zheng,et al. Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus , 2010, Science Translational Medicine.
[7] Pete Martin,et al. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study , 2008, BMJ : British Medical Journal.
[8] Lin Tang,et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. , 2011, American journal of obstetrics and gynecology.
[9] T. Leung,et al. Non‐invasive prenatal detection of fetal trisomy 18 by RNA–SNP allelic ratio analysis using maternal plasma SERPINB2 mRNA: a feasibility study , 2009, Prenatal diagnosis.
[10] Tak Y. Leung,et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy , 2007, Proceedings of the National Academy of Sciences.
[11] C. Wright,et al. Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing , 2009, BMJ : British Medical Journal.
[12] R. Chiu,et al. Innovations: Prenatal diagnosis: progress through plasma nucleic acids , 2007, Nature Reviews Genetics.
[13] Juliane C. Dohm,et al. Substantial biases in ultra-short read data sets from high-throughput DNA sequencing , 2008, Nucleic acids research.
[14] C. Cantor,et al. Non-invasive prenatal diagnosis by single molecule counting technologies. , 2009, Trends in genetics : TIG.
[15] R. Chiu,et al. Prenatal diagnosis: progress through plasma nucleic acids. , 2007, Nature reviews. Genetics.
[16] R. Snijders,et al. First-trimester screening for trisomies 21 and 18 , 2003 .
[17] K. McKernan,et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. , 2010, Clinical chemistry.
[18] C. Ding,et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. , 2006, Clinical chemistry.
[19] L. Poon,et al. Clinical Chemistry 47:9 1607–1613 (2001) Molecular Diagnostics and Genetics Effects of Blood-Processing Protocols on Fetal and Total DNA Quantification in Maternal Plasma , 2001 .
[20] N M Hjelm,et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. , 1998, The New England journal of medicine.
[21] I. Sargent,et al. Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.
[22] C. Ding,et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. , 2010, Clinical chemistry.
[23] H. C. Fan,et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood , 2008, Proceedings of the National Academy of Sciences.
[24] E. Gerdts. Letter: Cervical cancer and gonorrhoea. , 1974, Lancet.
[25] J. Kitzman,et al. Personalized Copy-Number and Segmental Duplication Maps using Next-Generation Sequencing , 2009, Nature Genetics.
[26] K. Ohama,et al. Cell-free fetal DNA in maternal circulation after amniocentesis. , 2003, Clinical chemistry.
[27] Huanming Yang,et al. SNP detection for massively parallel whole-genome resequencing. , 2009, Genome research.
[28] Stephen R. Quake,et al. Sensitivity of Noninvasive Prenatal Detection of Fetal Aneuploidy from Maternal Plasma Using Shotgun Sequencing Is Limited Only by Counting Statistics , 2010, PloS one.
[29] N. Carter,et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. , 2009, American Journal of Pathology.
[30] A. Hui,et al. Size distributions of maternal and fetal DNA in maternal plasma. , 2004, Clinical chemistry.
[31] Charles R Cantor,et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection , 2007, Nature Medicine.
[32] Yama W. L. Zheng,et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011, BMJ : British Medical Journal.